Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity Published in JAMA Neurology
The Journal of the American Medical Association (JAMA Neurology) publication [...]
Verve Medical Treats First Patient in Landmark U.S. Pilot Trial for Uncontrolled Hypertension, Advancing Momentum from Breakthrough TUSK Results
Verve Medical, the leader in non‑invasive renal pelvic denervation (RPD) [...]
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidism
Following End-of-Phase 2 meeting, MBX remains on track to initiate [...]
Medicus Pharma reports positive Phase 2 SKNJCT-003 Topline Data observing 73% Clinical Clearance and 40% Histological Clearance at day 57
The company is expected to finalize the Clinical Study Report [...]
Gut Bacteria and Diet Can Reprogram Fat to Burn More Energy According to A Recent Study
Findings published in Nature uncover a microbiome-driven pathway that turns [...]
Blue Earth Diagnostics Reports Favorable Head‑to‑Head Study Results Comparing POSLUMA® (Flotufolastat F 18) and Piflufolastat F 18 for Assessing Urinary Bladder Radioactivity in Men with Biochemical Recurrent Prostate Cancer
“This rigorous head-to-head study provides high-quality evidence that POSLUMA has [...]
Study highlights GLP-1 companion effects, underscoring capability of Brightseed’s AI platform to identify and launch clinically-validated, natural health innovations
The study was published in the peer-reviewed journal Bioactive Compounds [...]
Jupiter Endovascular Reports pivotal trial completed for flexible-to-stable catheter technology for pulmonary embolectomy
Trial Evaluates Safety, Right Heart Functional Improvement, and Clinical Outcomes [...]
Endospan Announces Positive 1 YR Data from TRIOMPHE FDA Pivotal Study For the NEXUS® Aortic Arch Stent-Graft System
The one-year results for the 94 high surgical risk patients [...]
First Patient Treated in Myra Vision’s U.S. ADAPT Clinical Study for Glaucoma
The Calibreye System is for investigational use only and is [...]